Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History. The previous revision v3.5.3 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry (v3.5.3) was added to the study's history, replacing the previous revision (v3.5.2) and signaling an updated posting date for the record.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.2 was added, replacing v3.5.0. This appears to be a system update and does not change the study history data shown on the page.SummaryDifference0.1%

- Check70 days agoChange DetectedNew page revision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedThe version history now lists a new revision v3.4.3 and removes the previous v3.4.2 from the log.SummaryDifference0.1%

- Check84 days agoChange DetectedEntries in the Study Status and Contacts/Locations sections were added and removed, updating the trial's status and the list of participating sites.SummaryDifference0.1%

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.